Early androgenetic alopecia as a marker of insulin resistance

The previously proven association between androgenetic, alopecia and serious cardiovascular events raises a question of the common pathogenetic mechanism of these disorders. Our practice-based case-control study in men aged 19–50 years showed a strikingly increased risk of hyperinsulinaemia and insu...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2000-09, Vol.356 (9236), p.1165-1166
Main Authors: Matilainen, Veikko, Koskela, Pentti, Keinänen-Kiukaanniemi, Sirkka
Format: Article
Language:English
Subjects:
Adult
Alopecia - epidemiology
Alopecia - etiology
Alopecia - genetics
Antihypertensive Agents - adverse effects
Biological and medical sciences
Biomarkers
Body Mass Index
Cardiovascular diseases
Case-Control Studies
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Finland - epidemiology
Humans
Hypertension
Hypoglycemic Agents - adverse effects
Insulin Resistance
Male
Medical sciences
Middle Aged
Myocardial infarction
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c483t-f76d0c3e5da485e0264cb038dafb6a7fd2b808556bc324f1f4efd7f6c6fd1eb13
cites cdi_FETCH-LOGICAL-c483t-f76d0c3e5da485e0264cb038dafb6a7fd2b808556bc324f1f4efd7f6c6fd1eb13
container_end_page 1166
container_issue 9236
container_start_page 1165
container_title The Lancet (British edition)
container_volume 356
creator Matilainen, Veikko
Koskela, Pentti
Keinänen-Kiukaanniemi, Sirkka
description The previously proven association between androgenetic, alopecia and serious cardiovascular events raises a question of the common pathogenetic mechanism of these disorders. Our practice-based case-control study in men aged 19–50 years showed a strikingly increased risk of hyperinsulinaemia and insulin-resistance-associated disorders such as obesity, hypertension, and dislipidaemia in men with early onset of alopecia (
doi_str_mv 10.1016/S0140-6736(00)02763-X
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_199079697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S014067360002763X</els_id><sourcerecordid>62136611</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-f76d0c3e5da485e0264cb038dafb6a7fd2b808556bc324f1f4efd7f6c6fd1eb13</originalsourceid><addsrcrecordid>eNqFkMtKxDAUhoMozjj6CEoRF7qonrS5tAsRGcYLCC5UmF1IkxOJ1nZMOoJvb3QGXcpZnM33n8tHyD6FUwpUnD0AZZALWYpjgBMopCjz-QYZUyZZzpmcb5LxLzIiOzG-AAATwLfJiFIoU8GYnM90aD8z3dnQP2OHgzeZbvsFGq8zHTOdvenwiiHrXea7uGx9lwWMPg66M7hLtpxuI-6t-4Q8Xc0epzf53f317fTyLjesKofcSWHBlMitZhVHKAQzDZSV1a4RWjpbNBVUnIvGlAVz1DF0VjphhLMUG1pOyOFq7iL070uMg3rpl6FLKxWta5C1qGWC-AoyoY8xoFOL4NP1n4qC-namfpypbyEKQP04U_OUO1gPXzZvaP9Sa0kJOFoDOhrdupBe9_GP41DQmifsYoVhMvHhMahoPCZL1gc0g7K9_-eSLwCPiFg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199079697</pqid></control><display><type>article</type><title>Early androgenetic alopecia as a marker of insulin resistance</title><source>Business Source Ultimate</source><source>ScienceDirect Freedom Collection</source><creator>Matilainen, Veikko ; Koskela, Pentti ; Keinänen-Kiukaanniemi, Sirkka</creator><creatorcontrib>Matilainen, Veikko ; Koskela, Pentti ; Keinänen-Kiukaanniemi, Sirkka</creatorcontrib><description>The previously proven association between androgenetic, alopecia and serious cardiovascular events raises a question of the common pathogenetic mechanism of these disorders. Our practice-based case-control study in men aged 19–50 years showed a strikingly increased risk of hyperinsulinaemia and insulin-resistance-associated disorders such as obesity, hypertension, and dislipidaemia in men with early onset of alopecia (&lt;35), compared with age-matched controls. This finding supports the hypothesis that early androgenetic alopecia could be a clinical marker of insulin resistance</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(00)02763-X</identifier><identifier>PMID: 11030300</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Adult ; Alopecia - epidemiology ; Alopecia - etiology ; Alopecia - genetics ; Antihypertensive Agents - adverse effects ; Biological and medical sciences ; Biomarkers ; Body Mass Index ; Cardiovascular diseases ; Case-Control Studies ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Finland - epidemiology ; Humans ; Hypertension ; Hypoglycemic Agents - adverse effects ; Insulin Resistance ; Male ; Medical sciences ; Middle Aged ; Myocardial infarction ; Risk Factors</subject><ispartof>The Lancet (British edition), 2000-09, Vol.356 (9236), p.1165-1166</ispartof><rights>2000 Elsevier Ltd</rights><rights>2000 INIST-CNRS</rights><rights>Copyright Lancet Ltd. Sep 30, 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-f76d0c3e5da485e0264cb038dafb6a7fd2b808556bc324f1f4efd7f6c6fd1eb13</citedby><cites>FETCH-LOGICAL-c483t-f76d0c3e5da485e0264cb038dafb6a7fd2b808556bc324f1f4efd7f6c6fd1eb13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1502195$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11030300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matilainen, Veikko</creatorcontrib><creatorcontrib>Koskela, Pentti</creatorcontrib><creatorcontrib>Keinänen-Kiukaanniemi, Sirkka</creatorcontrib><title>Early androgenetic alopecia as a marker of insulin resistance</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>The previously proven association between androgenetic, alopecia and serious cardiovascular events raises a question of the common pathogenetic mechanism of these disorders. Our practice-based case-control study in men aged 19–50 years showed a strikingly increased risk of hyperinsulinaemia and insulin-resistance-associated disorders such as obesity, hypertension, and dislipidaemia in men with early onset of alopecia (&lt;35), compared with age-matched controls. This finding supports the hypothesis that early androgenetic alopecia could be a clinical marker of insulin resistance</description><subject>Adult</subject><subject>Alopecia - epidemiology</subject><subject>Alopecia - etiology</subject><subject>Alopecia - genetics</subject><subject>Antihypertensive Agents - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Body Mass Index</subject><subject>Cardiovascular diseases</subject><subject>Case-Control Studies</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Finland - epidemiology</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Insulin Resistance</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial infarction</subject><subject>Risk Factors</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFkMtKxDAUhoMozjj6CEoRF7qonrS5tAsRGcYLCC5UmF1IkxOJ1nZMOoJvb3QGXcpZnM33n8tHyD6FUwpUnD0AZZALWYpjgBMopCjz-QYZUyZZzpmcb5LxLzIiOzG-AAATwLfJiFIoU8GYnM90aD8z3dnQP2OHgzeZbvsFGq8zHTOdvenwiiHrXea7uGx9lwWMPg66M7hLtpxuI-6t-4Q8Xc0epzf53f317fTyLjesKofcSWHBlMitZhVHKAQzDZSV1a4RWjpbNBVUnIvGlAVz1DF0VjphhLMUG1pOyOFq7iL070uMg3rpl6FLKxWta5C1qGWC-AoyoY8xoFOL4NP1n4qC-namfpypbyEKQP04U_OUO1gPXzZvaP9Sa0kJOFoDOhrdupBe9_GP41DQmifsYoVhMvHhMahoPCZL1gc0g7K9_-eSLwCPiFg</recordid><startdate>20000930</startdate><enddate>20000930</enddate><creator>Matilainen, Veikko</creator><creator>Koskela, Pentti</creator><creator>Keinänen-Kiukaanniemi, Sirkka</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20000930</creationdate><title>Early androgenetic alopecia as a marker of insulin resistance</title><author>Matilainen, Veikko ; Koskela, Pentti ; Keinänen-Kiukaanniemi, Sirkka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-f76d0c3e5da485e0264cb038dafb6a7fd2b808556bc324f1f4efd7f6c6fd1eb13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Alopecia - epidemiology</topic><topic>Alopecia - etiology</topic><topic>Alopecia - genetics</topic><topic>Antihypertensive Agents - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Body Mass Index</topic><topic>Cardiovascular diseases</topic><topic>Case-Control Studies</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Finland - epidemiology</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Insulin Resistance</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial infarction</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matilainen, Veikko</creatorcontrib><creatorcontrib>Koskela, Pentti</creatorcontrib><creatorcontrib>Keinänen-Kiukaanniemi, Sirkka</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matilainen, Veikko</au><au>Koskela, Pentti</au><au>Keinänen-Kiukaanniemi, Sirkka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early androgenetic alopecia as a marker of insulin resistance</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2000-09-30</date><risdate>2000</risdate><volume>356</volume><issue>9236</issue><spage>1165</spage><epage>1166</epage><pages>1165-1166</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>The previously proven association between androgenetic, alopecia and serious cardiovascular events raises a question of the common pathogenetic mechanism of these disorders. Our practice-based case-control study in men aged 19–50 years showed a strikingly increased risk of hyperinsulinaemia and insulin-resistance-associated disorders such as obesity, hypertension, and dislipidaemia in men with early onset of alopecia (&lt;35), compared with age-matched controls. This finding supports the hypothesis that early androgenetic alopecia could be a clinical marker of insulin resistance</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>11030300</pmid><doi>10.1016/S0140-6736(00)02763-X</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2000-09, Vol.356 (9236), p.1165-1166
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_journals_199079697
source Business Source Ultimate; ScienceDirect Freedom Collection
subjects Adult
Alopecia - epidemiology
Alopecia - etiology
Alopecia - genetics
Antihypertensive Agents - adverse effects
Biological and medical sciences
Biomarkers
Body Mass Index
Cardiovascular diseases
Case-Control Studies
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Finland - epidemiology
Humans
Hypertension
Hypoglycemic Agents - adverse effects
Insulin Resistance
Male
Medical sciences
Middle Aged
Myocardial infarction
Risk Factors
title Early androgenetic alopecia as a marker of insulin resistance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T05%3A33%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20androgenetic%20alopecia%20as%20a%20marker%20of%20insulin%20resistance&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Matilainen,%20Veikko&rft.date=2000-09-30&rft.volume=356&rft.issue=9236&rft.spage=1165&rft.epage=1166&rft.pages=1165-1166&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(00)02763-X&rft_dat=%3Cproquest_cross%3E62136611%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c483t-f76d0c3e5da485e0264cb038dafb6a7fd2b808556bc324f1f4efd7f6c6fd1eb13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199079697&rft_id=info:pmid/11030300&rfr_iscdi=true